Paul R. McGuirk
Direktor/Vorstandsmitglied bei GARDINER HEALTHCARE ACQUISITIONS CORP.
Profil
Paul R.
McGuirk is currently the Director, Chief Development Officer & Executive VP at Gardiner Healthcare Acquisitions Corp.
and also holds the position of Chief Development Officer & Executive VP at Gardiner Founder LLC and President at PRM Pharmaceuticals LLC.
Previously, he worked as the Executive Director at Chemical Technologies, Inc. and as the Chief Technology Officer, Director & EVP at Aeromics, Inc. from 2009 to 2020.
Prior to that, he worked at Pfizer Inc. for 27 years as the Manager-Infectious Diseases Medicinal Chemistry.
Aktive Positionen von Paul R. McGuirk
| Unternehmen | Position | Beginn |
|---|---|---|
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Direktor/Vorstandsmitglied | 01.04.2021 |
| PRM Pharmaceuticals LLC | Präsident | - |
| Gardiner Founder LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul R. McGuirk
| Unternehmen | Position | Ende |
|---|---|---|
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2009 |
Chemical Technologies, Inc.
 Chemical Technologies, Inc. Contract DrillingIndustrial Services Part of Newpark Resources, Inc., Chemical Technologies, Inc. provides retail drilling fluids services. The company is based in Warren. Chemical Technologies was acquired by Newpark Resources, Inc. on June 03, 1997 for $5 million. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Gardiner Healthcare Acquisitions Corp.
 Gardiner Healthcare Acquisitions Corp. Financial ConglomeratesFinance Gardiner Healthcare Acquisitions Corp. is a blank check company, which engages in merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The company was founded on March 25, 2021 and is headquartered in Shaker Heights, OH. | Finance |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Chemical Technologies, Inc.
Chemical Technologies, Inc. Contract DrillingIndustrial Services Part of Newpark Resources, Inc., Chemical Technologies, Inc. provides retail drilling fluids services. The company is based in Warren. Chemical Technologies was acquired by Newpark Resources, Inc. on June 03, 1997 for $5 million. | Industrial Services |
| PRM Pharmaceuticals LLC | |
| Gardiner Founder LLC |
